|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen LT, Xu SD, Xu H, Zhang JF, Ning JF
and Wang SF: MicroRNA-378 is associated with non-small cell lung
cancer brain metastasis by promoting cell migration, invasion and
tumor angiogenesis. Med Oncol. 29:1673–1680. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guo B, Liu L, Yao J, Ma R, Chang D, Li Z,
Song T and Huang C: miR-338-3p suppresses gastric cancer
progression through a PTEN-AKT axis by targeting P-REX2a. Mol
Cancer Res. 12:313–321. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shi Y, Luo X, Li P, Tan J, Wang X, Xiang T
and Ren G: miR-7-5p suppresses cell proliferation and induces
apoptosis of breast cancer cells mainly by targeting REGγ. Cancer
Lett. 358:27–36. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Roush S and Slack FJ: The let-7 family of
microRNAs. Trends Cell Biol. 18:505–516. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Akao Y, Nakagawa Y and Naoe T: let-7
microRNA functions as a potential growth suppressor in human colon
cancer cells. Biol Pharm Bull. 29:903–906. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esquela-Kerscher A, Trang P, Wiggins JF,
Patrawala L, Cheng A, Ford L, Weidhaas JB, Brown D, Bader AG and
Slack FJ: The let-7 microRNA reduces tumor growth in mouse models
of lung cancer. Cell Cycle. 7:759–764. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nadiminty N, Tummala R, Lou W, Zhu Y,
Zhang J, Chen X, White RW eVere, Kung HJ, Evans CP and Gao AC:
MicroRNA let-7c suppresses androgen receptor expression and
activity via regulation of Myc expression in prostate cancer cells.
J Biol Chem. 287:1527–1537. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nwaeburu CC, Bauer N, Zhao Z, Abukiwan A,
Gladkich J, Benner A and Herr I: Up-regulation of microRNA let-7c
by quercetin inhibits pancreatic cancer progression by activation
of Numbl. Oncotarget. 7:58367–58380. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu X, Wu L, Yao J, Jiang H, Wang Q, Yang
Z and Wu F: MicroRNA let-7c inhibits cell proliferation and induces
cell cycle arrest by targeting CDC25A in human hepatocellular
carcinoma. PLoS One. 10:e01242662015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han HB, Gu J, Zuo HJ, Chen ZG, Zhao W, Li
M, Ji DB, Lu YY and Zhang ZQ: Let-7c functions as a metastasis
suppressor by targeting MMP11 and PBX3 in colorectal cancer. J
Pathol. 226:544–555. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao B, Han H, Chen J, Zhang Z, Li S, Fang
F, Zheng Q, Ma Y, Zhang J, Wu N, et al: MicroRNA let-7c inhibits
migration and invasion of human non-small cell lung cancer by
targeting ITGB3 and MAP4K3. Cancer Lett. 342:43–51. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mao Y, Wu S, Zhao R and Deng Q: MiR-205
promotes proliferation, migration and invasion of nasopharyngeal
carcinoma cells by activation of AKT signalling. J Int Med Res.
44:231–240. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K,
Ren G, Su T, Pan Y, Feng B, et al: MiR-150 promotes gastric cancer
proliferation by negatively regulating the pro-apoptotic gene EGR2.
Biochem Biophys Res Commun. 392:340–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sarver AL, Li L and Subramanian S:
MicroRNA miR-183 functions as an oncogene by targeting the
transcription factor EGR1 and promoting tumor cell migration.
Cancer Res. 70:9570–9580. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou MK, Liu XJ, Zhao ZG and Cheng YM:
MicroRNA-100 functions as a tumor suppressor by inhibiting Lgr5
expression in colon cancer cells. Mol Med Rep. 11:2947–2952.
2015.PubMed/NCBI
|
|
19
|
Park SM, Shell S, Radjabi AR, Schickel R,
Feig C, Boyerinas B, Dinulescu DM, Lengyel E and Peter ME: Let-7
prevents early cancer progression by suppressing expression of the
embryonic gene HMGA2. Cell Cycle. 6:2585–2590. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li XX, Gao SY, Wang PY, Zhou X, Li YJ, Yu
Y, Yan YF, Zhang HH, Lv CJ, Zhou HH, et al: Reduced expression
levels of let-7c in human breast cancer patients. Oncol Lett.
9:1207–1212. 2015.PubMed/NCBI
|
|
21
|
Sun X, Xu C, Tang SC, Wang J, Wang H, Wang
P, Du N, Qin S, Li G, Xu S, et al: Let-7c blocks estrogen-activated
Wnt signaling in induction of self-renewal of breast cancer stem
cells. Cancer Gene Ther. 23:83–89. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pillai RS, Bhattacharyya SN and Filipowicz
W: Repression of protein synthesis by miRNAs: How many mechanisms?
Trends Cell Biol. 17:118–126. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Selby CP and Sancar A: Human
transcription-repair coupling factor CSB/ERCC6 is a DNA-stimulated
ATPase but is not a helicase and does not disrupt the ternary
transcription complex of stalled RNA polymerase II. J Biol Chem.
272:1885–1890. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ghai SJ, Shago M, Shroff M and Yoon G:
Cockayne syndrome caused by paternally inherited 5 Mb deletion of
10q11.2 and a frameshift mutation of ERCC6. Eur J Med Genet.
54:272–276. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma H, Hu Z, Wang H, Jin G, Wang Y, Sun W,
Chen D, Tian T, Jin L, Wei Q, et al: ERCC6/CSB gene polymorphisms
and lung cancer risk. Cancer Lett. 273:172–176. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chiu CF, Tsai MH, Tseng HC, Wang CL, Tsai
FJ, Lin CC and Bau DT: A novel single nucleotide polymorphism in
ERCC6 gene is associated with oral cancer susceptibility in
Taiwanese patients. Oral Oncol. 44:582–586. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu JW, He CY, Sun LP, Xu Q, Xing CZ and
Yuan Y: The DNA repair gene ERCC6 rs1917799 polymorphism is
associated with gastric cancer risk in Chinese. Asian Pac J Cancer
Prev. 14:6103–6108. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Leung HW, Wu CH, Lin CH and Lee HZ:
Luteolin induced DNA damage leading to human lung squamous
carcinoma CH27 cell apoptosis. Eur J Pharmacol. 508:77–83. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kaina B: DNA damage-triggered apoptosis:
Critical role of DNA repair, double-strand breaks, cell
proliferation and signaling. Biochem Pharmacol. 66:1547–1554. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Minocherhomji S, Ying S, Bjerregaard VA,
Bursomanno S, Aleliunaite A, Wu W, Mankouri HW, Shen H, Liu Y and
Hickson ID: Replication stress activates DNA repair synthesis in
mitosis. Nature. 528:286–290. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Burrell RA, McClelland SE, Endesfelder D,
Groth P, Weller MC, Shaikh N, Domingo E, Kanu N, Dewhurst SM,
Gronroos E, et al: Replication stress links structural and
numerical cancer chromosomal instability. Nature. 494:492–496.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kasyanenko N: DNA as a target for
anticancer drugs based on the coordination compounds of metals.
FEBS J. 280:89. 2013.
|
|
34
|
O'Grady S, Finn SP, Cuffe S, Richard DJ,
O'Byrne KJ and Barr MP: The role of DNA repair pathways in
cisplatin resistant lung cancer. Cancer Treat Rev. 40:1161–1170.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu H, Luo H, Zhang W, Shen Z, Hu X and
Zhu X: Molecular mechanisms of cisplatin resistance in cervical
cancer. Drug Des Devel Ther. 10:1885–1895. 2016. View Article : Google Scholar : PubMed/NCBI
|
